Stemline Therapeutics, Inc. (STML) related to its sale to Berlin-Chemie AG. Under the terms of the agreement, Stemline shareholders will have the right to receive (i) $11.50 in cash plus (ii) one contingent value right for each share of Stemline common stock owned.